Reversible inhibitors of the gastric H+/K+-transporting ATPase: a new class of anti-secretory agent

This publication has 10 references indexed in Scilit:

• Reversible inhibitors of the gastric (H+/K+)-ATPase as both potential therapeutic agents and probes of pump function
  Biochemical Society Transactions, 1992
• Oesophageal candidiasis after omeprazole therapy.
  Gut, 1992
• SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase
  Biochemical Pharmacology, 1991
• Phosphorylation of H+/K+-ATPase by inorganic phosphate. The role of K+ and SCH 28080
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1991
• Acid reduction and recurrent enteritis
  The Lancet, 1990
• Chapter 17. Agents for the Treatment of Peptic Ulcer Dlsease
  Published by Elsevier ,1990
• SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase
  Biochemical Pharmacology, 1988
• Structure—activity relationships of omeprazole analogues and their mechanism of action
  Trends in Pharmacological Sciences, 1987
• Mechanism of gastric antisecretory effect of SCH 28080
  British Journal of Pharmacology, 1986
• Pharmacology and Toxicology of Omeprazole with Special Reference to the Effects on the Gastric Mucosa
  Scandinavian Journal of Gastroenterology, 1986